Viewing StudyNCT02684032



Ignite Creation Date: 2024-05-06 @ 8:11 AM
Last Modification Date: 2024-10-26 @ 11:57 AM
Study NCT ID: NCT02684032
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2016-02-10

Brief Title: A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With PalbociclibLetrozole Or PalbociclibFulvestrant In Women With Metastatic Breast Cancer
Sponsor: Celcuity Inc
Organization: Celcuity Inc

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
PI3K phosphoinositide 3-kinase View
mTOR mechanistic target of rapamycin View
PI3KmTOR View
metastatic breast cancer MBC View
ER estrogen receptor positive View
HER2- human epidermal growth factor receptor 2 negative View